Detecting Fraud and Anti-Competitive Behaviour in the Australian Pharmaceutical and Medical Device Industries

Over 6 billion dollars of public money is expended each year under the Pharmaceutical Benefits Scheme (PBS)and public hospitals spend significant amounts on medical devices. Unlike Australia, in the United States strong anti-fraud and anti-trust legislation regularly recovers substantial public funds fraudulently obtained by pharmaceutical and medical device companies. This Project aims to unite experts in Australian pharmaceutical policy and high technology law enforcement with an eminent United States Partner Investigator in False Claims litigation to develop new legislative and evidentiary strategies to uncover fraud and anti-competitive behaviour in the Australian pharmaceutical and medical device industries.